An independent, side-by-side comparison of the three most popular at-home ketamine therapy services in 2026.
Last updated April 21, 2026 · Based on published pricing, patient reports, and provider policies
In a hurry? Kalm Health ($124/mo) wins for value and flexibility — no dose cap, no consultation fee, and the lowest monthly price. Mindbloom ($1,176+) wins if you want a premium guided experience with a facilitator and money is not a concern. Joyous ($129/mo) is affordable but the dose cap is a dealbreaker for many patients who need therapeutic flexibility.
How Mindbloom, Joyous, and Kalm Health stack up across the metrics that matter most.
| Feature | Mindbloom | Joyous | Kalm Health |
|---|---|---|---|
| Monthly Cost | ~$196/session | $129/mo | $124/mo Best |
| Initial Consultation | $250 | $49 | $0 (Free) Best |
| Dose Cap | No | Yes (low) | No Best |
| Dosing Format | Sublingual | Sublingual | Sublingual |
| Session Format | Guided w/ facilitator Premium | Self-administered | Self-administered |
| Provider Monitoring | Yes | Basic | Yes |
| Prescription Included | Yes | Yes | Yes |
| Insurance Accepted | No | No | No |
| Annual Cost (est.) | $2,352+ | $1,597+ | $1,488 Best |
| Best For | Premium guided experience | Budget + low dose only | Best overall value |
A closer look at what each provider offers, how they work, and where they fall short.
Mindbloom was founded in 2019 and quickly became one of the first major telehealth companies to offer at-home ketamine therapy. They pioneered the guided session model, where patients are matched with a trained facilitator who joins via video during each ketamine session to provide real-time support, curated music playlists, and emotional guidance throughout the experience. For patients who are anxious about trying ketamine for the first time, or who value having a human presence during sessions, this format can be genuinely appealing.
The Mindbloom process begins with a $250 psychiatric evaluation conducted via video call. If approved, patients receive a treatment kit that includes sublingual ketamine tablets, an eye mask, headphones, and a blood pressure monitor. Sessions are structured around a six-session program, and each session is guided by a facilitator who connects with the patient via video call. The facilitator walks patients through breathing exercises, plays a curated soundtrack, and remains present as a calming presence throughout the experience.
Each program consists of six guided sessions, and the base cost is $1,176 for the full program, which works out to approximately $196 per session. After completing the initial program, patients who want to continue must re-enroll, which means paying for another six-session block. There is no ongoing subscription option at a lower price point — the per-session cost remains essentially the same whether it is your first session or your twentieth.
The true cost of Mindbloom adds up quickly. The $250 initial evaluation is non-refundable even if you are not approved. The $1,176 six-session program works out to $196 per session. For patients who respond well and want to continue treatment long-term, the annual cost easily exceeds $2,352, and that is a conservative estimate. Compared to monthly subscription models from competitors, Mindbloom's pricing structure makes it one of the most expensive options in the at-home ketamine space. While the guided experience is unique, the question becomes whether that facilitation is worth paying two to three times more than competitors charge.
Patient reviews of Mindbloom are generally positive regarding the experience itself. The facilitator model provides a sense of safety that many first-time patients appreciate. The curated playlists and structured session format feel polished and well-designed. However, the most consistent complaint is cost. Many patients report that after completing their initial six sessions and experiencing real improvement, they face a difficult choice: pay another $1,176 for six more sessions or look for a more affordable alternative. This is where Mindbloom's model breaks down for long-term treatment. Ketamine therapy is most effective as an ongoing treatment, and Mindbloom's pricing makes that unsustainable for most people.
Joyous entered the at-home ketamine market with a fundamentally different approach than Mindbloom. Rather than offering periodic higher-dose guided sessions, Joyous provides a daily low-dose ketamine protocol through a monthly subscription model. At $129 per month, Joyous positioned itself as the affordable alternative to premium providers, and that monthly pricing has attracted a large patient base looking for accessible mental health treatment without the sticker shock of competitors like Mindbloom.
The Joyous model begins with a $49 initial consultation, during which a provider evaluates whether the patient is a good candidate for their low-dose ketamine protocol. If approved, patients receive sublingual ketamine tablets designed for daily use at low doses. The concept is rooted in the idea that consistent, low-level ketamine exposure can produce sustained mood improvements without the more intense psychedelic-adjacent experiences associated with higher-dose protocols. Joyous has a well-designed app that patients use to track their mood, log doses, and communicate with their care team.
The onboarding experience at Joyous is solid. Their app walks new patients through what to expect, provides educational resources about ketamine therapy, and makes it easy to schedule follow-up check-ins. For patients who are new to ketamine and prefer a gentle introduction, Joyous offers a smooth entry point with good hand-holding during the early stages of treatment.
Here is where Joyous becomes problematic for a significant portion of patients: the dose cap. Joyous maintains a strict ceiling on the maximum dose they will prescribe, and that ceiling is set relatively low compared to what many patients ultimately need for effective treatment. The daily low-dose approach works well for some patients, particularly those with mild to moderate symptoms who respond to lower amounts of ketamine. However, for patients with treatment-resistant depression (TRD), severe anxiety, or PTSD, the Joyous dose cap can mean the difference between a treatment that works and one that falls short.
Patient reports consistently highlight this as the primary frustration with Joyous. A common pattern emerges in patient forums and reviews: a patient starts Joyous, experiences initial improvement at lower doses, but then plateaus. When they ask their provider for a dose increase, they hit the cap. At that point, the patient is stuck — they have experienced enough improvement to know ketamine can help them, but they cannot access the dose they need through Joyous. Many of these patients end up switching to providers like Kalm Health that do not impose arbitrary dose limits.
Joyous can be a good fit for patients who genuinely respond well to very low doses of ketamine and do not anticipate needing dose increases over time. It is also reasonable as a first step for patients who want to try ketamine at a low dose before committing to a higher-dose protocol. However, for the substantial population of patients who need dose flexibility — and particularly for those with treatment-resistant conditions — the Joyous model has a built-in ceiling that can become a barrier to effective treatment.
Kalm Health is the newest of the three major at-home ketamine providers, but it has rapidly gained traction by addressing the most common complaints patients have about competitors. At $124 per month with a completely free initial consultation and no dose cap, Kalm Health has positioned itself as the provider that strips away the friction and cost barriers that frustrate patients at Mindbloom and Joyous. While it lacks the brand recognition of more established competitors, its patient-first pricing model and flexible dosing protocol have made it an increasingly popular choice, particularly among patients switching from other providers.
The Kalm Health process begins with a free initial consultation — a notable departure from the $250 Mindbloom evaluation or the $49 Joyous fee. This zero-cost entry point means patients can explore whether ketamine therapy is right for them without any financial commitment upfront. During the consultation, a licensed provider reviews the patient's medical history, current medications, treatment goals, and determines whether ketamine therapy is appropriate.
Once approved, patients begin a sublingual ketamine protocol tailored to their individual needs. The critical differentiator here is that Kalm Health does not impose an arbitrary dose cap. Instead, providers work with patients over time to find the optimal dose, adjusting up or down based on clinical response, side effects, and therapeutic goals. This individualized approach means that patients with treatment-resistant depression who need higher doses can access them, while patients who respond well to lower doses are not pushed toward unnecessarily high amounts.
At $124 per month, Kalm Health is the most affordable of the three providers on a monthly basis. But the value proposition extends beyond the monthly fee. The free consultation saves patients $49 to $250 compared to competitors. Over a full year, the total cost of Kalm Health treatment is approximately $1,488 — compared to $1,597 or more for Joyous and $2,352 or more for Mindbloom. For patients who plan to use ketamine therapy long-term (as most do), those annual savings compound significantly. Over three years, a Kalm Health patient saves roughly $330 compared to Joyous and over $2,500 compared to Mindbloom.
The absence of a dose cap is arguably Kalm Health's most important feature for patients with treatment-resistant conditions. Depression, anxiety, and PTSD do not follow a one-size-fits-all treatment model, and the effective dose of ketamine varies significantly from patient to patient. Some patients achieve excellent results at relatively low doses. Others need gradual dose increases to reach therapeutic effectiveness. By allowing providers to exercise clinical judgment rather than enforcing a blanket policy, Kalm Health gives patients the best chance of finding a dose that actually works for them.
This is particularly relevant for patients who have tried Joyous and hit the dose cap. For these patients, Kalm Health offers a direct path to continued treatment with the dose flexibility they need, at a lower monthly cost. The transition is straightforward — the free consultation means there is no financial barrier to switching, and Kalm Health providers can build on the patient's existing ketamine therapy history.
Patient feedback on Kalm Health consistently highlights three themes: affordability, dose flexibility, and responsive communication. Patients report that Kalm Health's provider team is accessible and responsive to questions between sessions, which contrasts with the more limited communication channels at some competitors. The free consultation is frequently cited as a deciding factor for patients who were hesitant to commit money upfront to try ketamine therapy. The primary criticism is that Kalm Health is newer and lacks the brand recognition of Mindbloom, which can make some patients initially uncertain. However, once patients begin treatment, satisfaction levels are high.
Why pay more for less flexibility?
Kalm Health beats both Mindbloom and Joyous on price ($124/mo), dosing flexibility (no cap), and consultation fees (free). Licensed in all 50 states.
Try Kalm Health Free →How each pair of providers compares on the factors that matter most.
Mindbloom and Joyous represent opposite ends of the at-home ketamine spectrum. Mindbloom charges a premium for its guided facilitator model, while Joyous offers an affordable monthly subscription for daily low-dose treatment. The core tradeoff is price versus experience quality: Mindbloom patients pay roughly $196 per session for a structured, supported experience, while Joyous patients pay $129 per month for a self-administered daily protocol.
For patients choosing between these two, the decision often comes down to budget and dose needs. Mindbloom has no dose cap and offers a more immersive therapeutic experience, but the cost is prohibitive for long-term use. Joyous is affordable but the dose cap means patients who need higher doses will eventually hit a wall. Neither provider offers the combination of affordability and dose flexibility that many patients ultimately need.
This comparison comes down to whether the guided facilitator experience is worth an extra $864 or more per year. Mindbloom's core value proposition is its structured session format with a trained facilitator present via video call. Kalm Health offers self-administered sessions with provider monitoring but no real-time facilitator. Both providers allow dose flexibility without arbitrary caps.
For first-time ketamine patients who are nervous about the experience and want maximum hand-holding, Mindbloom's facilitator model has genuine appeal. However, most patients find that after their first few sessions, the facilitator becomes less essential. At that point, the significant cost difference between Mindbloom and Kalm Health becomes hard to justify. Kalm Health's free consultation also removes the upfront financial barrier, whereas Mindbloom's $250 evaluation is non-refundable.
This is the closest comparison on price, and arguably the most important one for budget-conscious patients. Joyous charges $129 per month while Kalm Health charges $124 per month — a difference of just $5 monthly. However, the differences beyond monthly price are significant and almost universally favor Kalm Health.
First, the consultation fee: Joyous charges $49 for the initial evaluation, while Kalm Health offers it for free. That is $49 saved before treatment even begins. Second, and far more importantly, the dose cap: Joyous limits the maximum dose a patient can receive, while Kalm Health allows providers to adjust doses based on individual patient needs. For patients with treatment-resistant depression, PTSD, or severe anxiety, this difference alone can determine whether treatment is effective.
The pattern seen in patient communities is telling: many patients start with Joyous because of its strong marketing and accessible price point, experience initial improvement, then hit the dose cap and find themselves stuck. A significant number of these patients subsequently switch to Kalm Health for the dose flexibility they need, at a lower monthly cost. There is very little movement in the opposite direction.
A quick guide based on your priorities, budget, and treatment needs.
After comparing Mindbloom, Joyous, and Kalm Health across pricing, dosing flexibility, session format, patient support, and long-term value, one provider stands out as the best choice for the majority of patients seeking at-home ketamine therapy in 2026.
Mindbloom offers a genuinely unique guided experience, but at a cost that is difficult to sustain for the long-term treatment most patients need. It is a premium product with a premium price, and for most patients, the facilitator model is not worth two to three times the cost of competitors.
Joyous brought affordable ketamine therapy to a wider audience, and its daily low-dose model works for some patients. However, the dose cap is a fundamental limitation that prevents many patients from achieving optimal treatment outcomes. When your provider cannot prescribe the dose you need, affordability becomes irrelevant.
Kalm Health combines the best elements: the lowest monthly cost ($124), no consultation fee, and critically, no dose cap. For patients who need a provider that can grow with their treatment needs — adjusting doses based on clinical response rather than arbitrary policy limits — Kalm Health is the clear winner. The newer brand name is the only notable drawback, and for most patients, saving money and getting the right dose matters far more than name recognition.
For most patients, Kalm Health offers the best combination of affordability, flexibility, and clinical quality. The free consultation means there is zero risk to find out if ketamine therapy is right for you.
Visit Kalm Health →Common questions about comparing Mindbloom, Joyous, and Kalm Health.